These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial. Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M BMC Health Serv Res; 2015 Nov; 15():511. PubMed ID: 26573461 [TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of Strategies for Offering Influenza Vaccine in the Pediatric Emergency Department. Hart RJ; Stevenson MD; Smith MJ; LaJoie AS; Cross K JAMA Pediatr; 2018 Jan; 172(1):e173879. PubMed ID: 29114729 [TBL] [Abstract][Full Text] [Related]
7. Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany. Damm O; Eichner M; Rose MA; Knuf M; Wutzler P; Liese JG; Krüger H; Greiner W Eur J Health Econ; 2015 Jun; 16(5):471-88. PubMed ID: 24859492 [TBL] [Abstract][Full Text] [Related]
8. Net Costs Due to Seasonal Influenza Vaccination--United States, 2005-2009. Carias C; Reed C; Kim IK; Foppa IM; Biggerstaff M; Meltzer MI; Finelli L; Swerdlow DL PLoS One; 2015; 10(7):e0132922. PubMed ID: 26230271 [TBL] [Abstract][Full Text] [Related]
9. Household-based costs and benefits of vaccinating healthy children in daycare against influenza virus: results from a pilot study. Pisu M; Meltzer MI; Hurwitz ES; Haber M Pharmacoeconomics; 2005; 23(1):55-67. PubMed ID: 15693728 [TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness analysis of elementary school-located vaccination against influenza--results from a randomized controlled trial. Yoo BK; Humiston SG; Szilagyi PG; Schaffer SJ; Long C; Kolasa M Vaccine; 2013 Apr; 31(17):2156-64. PubMed ID: 23499607 [TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States. Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851 [TBL] [Abstract][Full Text] [Related]
12. Estimating the Effect of a National Pharmacy-Led Influenza Vaccination Voucher Program on Morbidity, Mortality, and Costs. Singh T; Taitel M; Loy D; Smith-Ray R J Manag Care Spec Pharm; 2020 Jan; 26(1):42-47. PubMed ID: 31880234 [TBL] [Abstract][Full Text] [Related]
13. Cost effectiveness of an inpatient influenza immunization assessment and delivery program for children with asthma. Teufel RJ; Basco WT; Simpson KN J Hosp Med; 2008 Mar; 3(2):134-41. PubMed ID: 18438789 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of influenza vaccination of healthy children. Salo H; Kilpi T; Sintonen H; Linna M; Peltola V; Heikkinen T Vaccine; 2006 Jun; 24(23):4934-41. PubMed ID: 16678945 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795 [TBL] [Abstract][Full Text] [Related]
17. Pharmacoeconomics of influenza vaccination for healthy working adults: reviewing the available evidence. Postma MJ; Jansema P; van Genugten ML; Heijnen ML; Jager JC; de Jong-van den Berg LT Drugs; 2002; 62(7):1013-24. PubMed ID: 11985488 [TBL] [Abstract][Full Text] [Related]
18. The effectiveness of vaccination against influenza in healthy, working adults. Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874 [TBL] [Abstract][Full Text] [Related]
19. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy]. Vitale F; Barbieri M; Dirodi B; Vitali Rosati G; Franco E Ann Ig; 2013; 25(1):43-56. PubMed ID: 23435779 [TBL] [Abstract][Full Text] [Related]
20. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs. Weycker D; Richardson E; Oster G Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]